Related Tags >> Celgene Velcade Onyx Pharmaceuticals NICE

Revlimid News

Most Popular Revlimid Story

UK patients lobby Celgene for discounts

October 28, 2008 — 10:24am ET | By Tracy Staton

When Johnson & Johnson made a pay-for-performance deal covering Velcade sales to the U.K.'s Read more...

Revlimid Press Releases

For the Treatment of Multiple Myeloma Hematologist-Oncologists Consider the Performance of Velcade More Favorably than Rev
Steve Jobs' Death Highlights Critical Need for New Therapies for Pancreatic Cancer
ImmunoGen, Inc. Announces Positive Clinical Data Presented on IMGN901 in the Treatment of Multiple Myeloma
The Highest Proportion of Surveyed Oncologists and MCOs Indicate That Bortezomib/Lenalidomide/Dexamethasone is the Most Ef
ImmunoGen, Inc. Announces Presentation of Positive Initial Clinical Data for IMGN901 Used in a Combination Regimen for Mul

Latest Headlines

Celgene halts Revlimid trial in prostate cancer
November 23, 2011
Analysts expect Revlimid to clear European safety review
September 21, 2011
NICE to assess uses for Botox, Revlimid, Tarceva
August 16, 2011
Study: Revlimid interaction may explain side effects
August 9, 2011
Revlimid maintenance use boosts survival, study shows
May 6, 2011
Celgene wasn't up-front on Revlimid data, analysts say
February 4, 2011
Two drugs, two price-setting tales
December 20, 2010
Celgene talks Revlimid defense strategy
August 26, 2010
Celgene faces patent challenge on key drug
August 25, 2010
Rituxan, Revlimid win in maintenance trials
May 21, 2010
Celgene ushers Hugin into CEO suite
April 30, 2010
More data supports broader Revlimid use
December 18, 2009
Celgene touts Revlimid as first-line treatment
December 8, 2009
Celgene drug could triple sales on new study
November 30, 2009
Behind the scenes as NICE talks Revlimid
June 8, 2009
Merck leads the way to U.S. cost-sharing
April 23, 2009
UK patients lobby Celgene for discounts
October 28, 2008
Revlimid linked to fatal skin reaction
September 19, 2008
ASCO already churning out news
May 30, 2008
Revlimid fuels Celgene sales rocket
January 7, 2008

Paid Research Reports

More Research Reports >>